Holger Reithinger
InvestorGeneral Partner at Forbion
Munich, Germany
Writes $100K – $5M checks · typically $1.5M
Find your path to Holger
153 people in our graph can introduce you to Holger.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Klaus Breiner to introduce you to Holger
You →Klaus · together at Global Life Science Ventures (2004) →Holger
Ask Jamie Chen to introduce you to Holger
You →Jamie · together at 4SC AG →Holger
Ask Sam Okafor to introduce you to Holger
You →Sam · 2 people · together at Omeicos Therapeutics →Holger
Sign up to find every way you can get introduced to Holger
- Your email: the people you already email who know Holger
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Holger
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Experience
- ForbionSenior Advisorcurrent2025 — presentMetropolregion München
- ForbionGeneral Partner2010 — 2025Munich Area, Germany
- BIO Deutschland e. V.Coordinatorcurrent2024 — presentBerlin, Germany
- High-Tech GründerfondsMember of the Investment Committeecurrent2017 — presentBonn Area, Germany
- Allecra TherapeuticsBoard Member2013 — 2023Lörrach
- Seamless TherapeuticsBoard Observer2022 — 2023Dresden, Saxony, Germany
- OMEICOS Therapeutics GmbHBoard Member2018 — 2022Berlin Area, Germany
- CatalYm GmbHChairman Of The Board2016 — 2021Munich Area, Germany
- Gotham TherapeuticsBoard Director2018 — 2020New York City
- Cellnovo Group SAMember of the Board2015 — 2018Paris Area, France
- Cellnovo Group SABoard Director2014 — 2015Swansea, United Kingdom
- Curetis GroupAufsichtsrat2015 — 2018
- Rigontec GmbHBoard Member2015 — 2017Bonn Area, Germany
- Curetis AGAufsichtsrat2011 — 2015Holzgerlingen
- Freie Waldorfschule Wolfratshausen - Gemeinnützige eGAufsichtsrat (Vorsitzender)2010 — 2013Wolfratshausen
- Santaris PharmaDirector2006 — 2010
- Fibrex Medical Inc.Director2005 — 2010
- Global Life Science VenturesPartner2004 — 2010
- 4SC AGAufsichtsrat2002 — 2004Munich Area, Germany
- 3i Deutschland GmbHDirector2000 — 2004
- Munich Biotech AGAufsichtsrat1998 — 2004
- Epigenomics AGVice Chairman1999 — 2001
- TechnologieholdingInvestment Manager / Associate1997 — 2000
- Whatman plc / BiometraProduct Development Manager1995 — 1997
Skills & more
+12 more
Angel InvestingMergers & AcquisitionsStart-upsLifesciencesProduct DevelopmentIPOLicensingCorporate DevelopmentEarly StagePharmaceutical IndustryStrategyLife SciencesLanguages English
From Holger's professional profile.
Investments
Investor
AgendiaAllecra Therapeutics GmbHCuretisGotham TherapeuticsOmeicos TherapeuticsSantaris Pharma
Per curated public sources.
Colleagues at Forbion
Network2
Investors connected to Holger in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Holger Reithinger?
- General Partner at Forbion
- Where does Holger Reithinger work?
- Holger Reithinger is General Partner at Forbion.
- What check size does Holger Reithinger write?
- Holger Reithinger typically writes checks of $100K – $5M.
- What companies has Holger Reithinger invested in?
- Investments tracked here include Agendia, Allecra Therapeutics GmbH, Curetis, Gotham Therapeutics, Omeicos Therapeutics, Santaris Pharma.
- Where did Holger Reithinger go to school?
- Holger Reithinger studied at MPI for Biophysics (PhD, Biochemistry); Ludwig-Maximilians-Universität München (Diplom, Biology); Heidelberg University (Vordiplom, Biology).
Same school
Also attended Ludwig-Maximilians-Universität München243
+ 237 more
Also attended Heidelberg University97
+ 91 more
Shared employers
Also worked at BIO Deutschland e. V.1
Also worked at High-Tech Gründerfonds40
+ 34 more
Also worked at OMEICOS Therapeutics GmbH3
Also worked at CatalYm GmbH11
+ 5 more















































